Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Belgium Nutraceuticals giant Eubage Laboratory to pump 17 Million US $ in Dr. Datsons Labs LtdThe Deal includes licensing out 20 innovative food supplements formulations to Dr. Datsons Labs to capture the flourishing $4 billion Neutraceutical Market in india.
The Deal includes licensing out 20 innovative food supplements formulations to Dr. Datsons Labs to capture the flourishing $4 billion Neutraceutical Market in india. Tuesday,20th January 2015, New Delhi : Belgium based Eubage Laboratory has striked a major partnership agreement with the Indian Pharma Company Dr. Datsons Labs Ltd specializing in Bulk drugs, Contract manufacturing Company which is the third-largest quinine salts manufacturer in the world and among the-largest controlled substances quota in India. As per the sources, Belgium Nutraceuticals giant Eubage Laboratory is expected to invest around Rs 100 crore in setting up a nutraceuticals manufacturing facility in the state of the art facility at Dr Datson’s UK-MHRA and EU-GMP-compliant facilities, & is ISO 9001:2008, ISO 14001:2004 and ISO 22000-certified Spanning 100,000 sq meters at unit at Mahad, Pune, India. Soon after the commissioning the plant & project by the Eubage Laboratory technical team next month. The plant initially will have a capacity of 200 tonnes annually and would scale up to 2,000 tonnes to cater to the domestic requirements of the country. Both the company are also in talks with various players in various parts of the world for exports of nutraceutical products wherever Belgium Nutraceuticals giant Eubage Laboratory is not present specially in middle east and it would be primarily to the European and other Asian countries. Pharmaceutical companies are the buyers for these products. Nutraceuticals is estimated to become $4 billion market in India by 2018 & the demand for this segment is growing with the forecast the Indian RTE food market is projected to grow at a CAGR of 22 per cent during 2014-19.With the passage of time and due to many international and local players in this segment, the percentage share rose with a rapid pace. Belgium company will license out 20 innovative food supplements formulations to Dr. Datsons Labs & will invest 100 Crore in Datson Labs Pune Factory. The Belgium delegation met the senior Board Members of Dr. Datsons Labs Ltd in Singapore to source some essential raw materials to be used for the finished formulations as the compositions in about six to seven products are not available in india. To confirm the news on this development, Pharmaleaders reached out to the promoters via mail/sms & voice, however, no one were available to comment till the release of this news, though the officials from the Eubage Laboratory confirmed the developments. The collaboration & investment by Eubage Laboratory include 100 crore funding to the new project to Dr. Datsons Labs Ltd, a technology transfer agreement, license out 20 innovative food supplements formulations to Dr. Datsons Labs, a top Indian Pharma company to market the range of 20 products that include the revolutionary ingredients to be launched for the first time in india. Both Indian & Belgium Company will market the products by a top Indian Pharma company with a pan india base to reach out growing markets. According to experts, nutraceuticals & functional foods would help mitigate malnutrition in India. Although, there is a huge potential for the growth of the sector, yet its development is slow. The country has a long way to go to en-cash much of its bio-agri wealth. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|